Literature DB >> 24842928

Identification of lysine residues in the Borrelia burgdorferi DbpA adhesin required for murine infection.

Danielle E Fortune1, Yi-Pin Lin2, Ranjit K Deka3, Ashley M Groshong1, Brendan P Moore1, Kayla E Hagman3, John M Leong2, Diana R Tomchick4, Jon S Blevins5.   

Abstract

Decorin-binding protein A (DbpA) of Borrelia burgdorferi mediates bacterial adhesion to heparin and dermatan sulfate associated with decorin. Lysines K82, K163, and K170 of DbpA are known to be important for in vitro interaction with decorin, and the DbpA structure, initially solved by nuclear magnetic resonance (NMR) spectroscopy, suggests these lysine residues colocalize in a pocket near the C terminus of the protein. In the current study, we solved the structure of DbpA from B. burgdorferi strain 297 using X-ray crystallography and confirmed the existing NMR structural data. In vitro binding experiments confirmed that recombinant DbpA proteins with mutations in K82, K163, or K170 did not bind decorin, which was due to an inability to interact with dermatan sulfate. Most importantly, we determined that the in vitro binding defect observed upon mutation of K82, K163, or K170 in DbpA also led to a defect during infection. The infectivity of B. burgdorferi expressing individual dbpA lysine point mutants was assessed in mice challenged via needle inoculation. Murine infection studies showed that strains expressing dbpA with mutations in K82, K163, and K170 were significantly attenuated and could not be cultured from any tissue. Proper expression and cellular localization of the mutated DbpA proteins were examined, and NMR spectroscopy determined that the mutant DbpA proteins were structurally similar to wild-type DbpA. Taken together, these data showed that lysines K82, K163, and K170 potentiate the binding of DbpA to dermatan sulfate and that an interaction(s) mediated by these lysines is essential for B. burgdorferi murine infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24842928      PMCID: PMC4136201          DOI: 10.1128/IAI.02036-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  80 in total

1.  Comparisons of NMR spectral quality and success in crystallization demonstrate that NMR and X-ray crystallography are complementary methods for small protein structure determination.

Authors:  David A Snyder; Yang Chen; Natalia G Denissova; Thomas Acton; James M Aramini; Melissa Ciano; Richard Karlin; Jinfeng Liu; Philip Manor; P A Rajan; Paolo Rossi; G V T Swapna; Rong Xiao; Burkhard Rost; John Hunt; Gaetano T Montelione
Journal:  J Am Chem Soc       Date:  2005-11-30       Impact factor: 15.419

2.  Miscellaneous algorithms for density modification.

Authors:  K Cowtan; P Main
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-07-01

Review 3.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  Decorin-binding adhesins from Borrelia burgdorferi.

Authors:  B P Guo; E L Brown; D W Dorward; L C Rosenberg; M Höök
Journal:  Mol Microbiol       Date:  1998-11       Impact factor: 3.501

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Resistance to Lyme disease in decorin-deficient mice.

Authors:  E L Brown; R M Wooten; B J Johnson; R V Iozzo; A Smith; M C Dolan; B P Guo; J J Weis; M Höök
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

7.  Adherence of Borrelia burgdorferi to the proteoglycan decorin.

Authors:  B P Guo; S J Norris; L C Rosenberg; M Höök
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.

Authors:  Aruna K Behera; Enrique Durand; Carla Cugini; Styliani Antonara; Lori Bourassa; Ethan Hildebrand; Linden T Hu; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2007-09-06       Impact factor: 3.715

9.  Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins.

Authors:  Peter Kraiczy; Jens Hellwage; Christine Skerka; Heiko Becker; Michael Kirschfink; Markus M Simon; Volker Brade; Peter F Zipfel; Reinhard Wallich
Journal:  J Biol Chem       Date:  2003-11-07       Impact factor: 5.157

10.  The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine Lyme borreliosis.

Authors:  Denise M Imai; D Scott Samuels; Sunlian Feng; Emir Hodzic; Kim Olsen; Stephen W Barthold
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

View more
  20 in total

1.  Structure of decorin binding protein B from Borrelia burgdorferi and its interactions with glycosaminoglycans.

Authors:  Wei Feng; Xu Wang
Journal:  Biochim Biophys Acta       Date:  2015-08-11

2.  Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease.

Authors:  Rebecca Byram; Robert A Gaultney; Angela M Floden; Christopher Hellekson; Brandee L Stone; Amy Bowman; Brian Stevenson; Barbara J B Johnson; Catherine A Brissette
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

3.  Host cell heparan sulfate glycosaminoglycans are ligands for OspF-related proteins of the Lyme disease spirochete.

Authors:  Yi-Pin Lin; Rudra Bhowmick; Jenifer Coburn; John M Leong
Journal:  Cell Microbiol       Date:  2015-05-13       Impact factor: 3.715

4.  Cyclic di-GMP modulates gene expression in Lyme disease spirochetes at the tick-mammal interface to promote spirochete survival during the blood meal and tick-to-mammal transmission.

Authors:  Melissa J Caimano; Star Dunham-Ems; Anna M Allard; Maria B Cassera; Melisha Kenedy; Justin D Radolf
Journal:  Infect Immun       Date:  2015-05-18       Impact factor: 3.441

5.  A short-term Borrelia burgdorferi infection model identifies tissue tropisms and bloodstream survival conferred by adhesion proteins.

Authors:  Jennifer A Caine; Jenifer Coburn
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

Review 6.  Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.

Authors:  Yi-Pin Lin; Lingyun Li; Fuming Zhang; Robert J Linhardt
Journal:  Microbiology       Date:  2017-11-08       Impact factor: 2.777

7.  The BB0345 Hypothetical Protein of Borrelia burgdorferi Is Essential for Mammalian Infection.

Authors:  Danielle E Graham; Ashley M Groshong; Clay D Jackson-Litteken; Brendan P Moore; Melissa J Caimano; Jon S Blevins
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

Review 8.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

9.  Non-anticoagulant Heparin as a Pre-exposure Prophylaxis Prevents Lyme Disease Infection.

Authors:  Yi-Pin Lin; Yanlei Yu; Ashley L Marcinkiewicz; Patricia Lederman; Thomas M Hart; Fuming Zhang; Robert J Linhardt
Journal:  ACS Infect Dis       Date:  2020-01-30       Impact factor: 5.084

10.  Middle region of the Borrelia burgdorferi surface-located protein 1 (Lmp1) interacts with host chondroitin-6-sulfate and independently facilitates infection.

Authors:  Xiuli Yang; Yi-Pin Lin; Ryan D Heselpoth; Ozlem Buyuktanir; Jinhong Qin; Faith Kung; Daniel C Nelson; John M Leong; Utpal Pal
Journal:  Cell Microbiol       Date:  2015-08-31       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.